Abiopharma

🔍 Lynch Jeannine (Executive)

Company: Lifeward Ltd. (LFWD)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 1,591 shares of Ordinary Shares, par value NIS 1.75 per share at $0.64 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 46,067.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents Ordinary Shares sold in the open market on September 2, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 31, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 31, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
• REMARKS: The automatic sell-to-cover arrangement is mandated by the terms of the Company's RSU grant agreement, dated as of the Grant Date, by and between the Company and the Reporting Person with respect to the payment of taxes upon vesting of the RSUs.